Clinical Trial

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to compare the efficacy and safety of DW1807 and DW1807-R2 in patients with perennial allergic rhinitis and comorbid asthma. The primary objective is to demonstrate the superiority of DW1807 over DW1807-R2 in improving the reflective total nasal symptom score (rTNSS) after 4 weeks of treatment.
Trial Details
NCT Number NCT07168473
Lead Sponsor Daewon Pharmaceutical Co., Ltd.
Conditions Perennial Allergic Rhinitis Accompanied by Asthma
Enrollment 274 participants
Start Date 2024-09-09
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-09-18 (estimated)
Updated on ClinicalTrials.gov 2025-09-11